ArticleTherapeutic advances in medical oncology2026

A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design.

Jingran Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.